Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Nov 24, 2020; 11(11): 935-944
Published online Nov 24, 2020. doi: 10.5306/wjco.v11.i11.935
Published online Nov 24, 2020. doi: 10.5306/wjco.v11.i11.935
Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria
Usman Malami Aliyu, Department of Radiotherapy and Oncology, Usmanu Danfodiyo University/Teaching Hospital, Sokoto 840212, Nigeria
Abdulrahaman Auwal Musa, Department of Histopathology, Usmanu Danfodiyo University Teaching Hospital, Sokoto 840221, Nigeria
Author contributions: Aliyu UM drafted the methodology and discussion; Musa AA assisted with data analysis and interpretation of the result; Aliyu UM and Musa AA performed the writing and editing for the original manuscript.
Institutional review board statement: This study was reviewed and approved by the Research Ethics Committee. The research topic is in line with the rule and regulation of the institution.
Conflict-of-interest statement: The authors of this manuscript have no conflicts of interest to disclose.
Data sharing statement: There are no additional data available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Usman Malami Aliyu, MBBS, Senior Lecturer, Department of Radiotherapy and Oncology, Usmanu Danfodiyo University/Teaching Hospital, No. 1 Garba Nadama Road, Gawon Nama Area, Sokoto 840212, Nigeria. aamusa08033@gmail.com
Received: April 23, 2020
Peer-review started: April 23, 2020
First decision: June 15, 2020
Revised: September 16, 2020
Accepted: October 5, 2020
Article in press: October 5, 2020
Published online: November 24, 2020
Processing time: 208 Days and 20.7 Hours
Peer-review started: April 23, 2020
First decision: June 15, 2020
Revised: September 16, 2020
Accepted: October 5, 2020
Article in press: October 5, 2020
Published online: November 24, 2020
Processing time: 208 Days and 20.7 Hours
Core Tip
Core Tip: Breast cancer is the most common malignancy in Nigeria as it is in the whole world. Assessment of immunohistochemical profile and its tumor characteristic is paramount to the management of this disease entity. The paucity of literature on breast cancer biomarkers in sub-Saharan Africa (e.g., Nigeria) has contributed to the increase in morbidity and mortality recorded in the region.